Cayman HU-211

The endocannabinoids present a rich system of central cannabinoid (CB₁), peripheral cannabinoid (CB₂), and non-CB receptor-mediated pharmacology that has stimulated research in many fields including memory, weight loss and appetite, neurodegeneration, tumor surveillance, analgesia, and inflammation.^, HU-211 is a synthetic terpene-based cannabinoid devoid of central cannabinoid (CB₁) and peripheral cannabinoid (CB₂) agonist activity, thus lacking the psychomotor responses characteristic of Δ⁹-THC. HU-211 does exhibit the neuroprotective, antioxidant properties of other related compounds like cannabidiol. HU-211 also has anti-inflammatory properties derived through inhibition of NF-κB and the resulting decreases in cytokines such as TNF-α and interleukin-6.

WARNING This product is not for human or veterinary use.